ONKOLOGIE / Onkologie. 2024;18(2):116-120 / www.onkologiecs.cz 120 HLAVNÍ TÉMA Význam mikrobiomu u hematoonkologických pacientů 5. Long Y, Tang L, Zhou Y, et al. Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study. BMC Med. 2023;21(1):66. 6. Zhou L, Zhang M, Wang Y, et al. Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1. Inflamm Bowel Dis. 2018;24(9):1926-1940. 7. Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe- -derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446-450. 8. Garrett WS. Cancer and the microbiota. Science. 2015;348(6230):80-86. 9. Guevara-Ramírez P, Cadena-Ullauri S, Paz-Cruz E, et al. Role of the gut microbiota in hematologic cancer. Front Microbiol. 2023;14:1185787. 10. Huang X, Cai H, Zhao Y, et al. The Gut Microbiome and Acute Leukemia: Implications for Early Diagnostic and New Therapies. Mol Nutr Food Res. 2023;e2300551. 11. Pflug N, Kluth S, Vehreschild JJ, et al. Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiota. Oncoimmunology. 2016;5(6):e1150399. 12. Yoon SE, Kang W, Choi S, et al. The influence of microbial dysbiosis on immunochemotherapy-related efficacy and safety in diffuse large B-cell lymphoma. Blood. 2023;141(18):2224-2238. 13. Pianko MJ, Devlin SM, Littmann ER, et al. Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition. Blood Adv. 2019;3(13):2040-2044. 14. Morales ML, Ferrer-Marín F. Deepening Our Understanding of the Factors Affecting Landscape of Myeloproliferative Neoplasms: What Do We Know about Them? Cancers. 2023;15(4):1348. 15. Jiang H, Zhao X, Zang M, et al. Gut Microbiome and Plasma Metabolomic Analysis in Patients with Myelodysplastic Syndrome. Oxid Med Cell Longev. 2022;2022:1482811. 16. Wang R, Yang X, Liu J, et al. Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate. Nat Commun [Internet]. 2022 [cited 2024 Jan 30];13. Available from: https://www.ncbi.nlm.nih. gov/pmc/articles/PMC9085760/. 17. Khan N, Lindner S, Gomes ALC, et al. Fecal microbiota diversity disruption and clinical outcomes after auto- -HCT: a multicenter observational study. Blood. 2021;137(11): 1527-1537. 18. Asokan S, Cullin N, Stein-Thoeringer CK, et al. CAR-T Cell Therapy and the Gut Microbiota. Cancers. 2023; 15(3):794. 19. Jiang H, Zhang Q. Gut microbiota influences the efficiency of immune checkpoint inhibitors by modulating the immune system (Review). Oncol Lett. 2024;27(2):87. PŘEDPLATNÝM ČASOPISU NA ROK 2024 ZÍSKÁTE 5 čísel ve vaší schránce — Tematická suplementa — Čtení na tabletech, PC a telefonech — Přístup do archivu časopisu on-line Cena předplatného na rok 2024: 1 350 Kč OBJEDNÁVEJTE www.onkologiecs.cz predplatne@solen.cz 585 204 335 Onkologie na rok 2024 Už máte předplaceno?
RkJQdWJsaXNoZXIy NDA4Mjc=